Trial intelligence / Profile preview

Albumin 4g/L vs 8g/L for PPCD Prevention

NCT00428506Phase 2Unknown

Sponsor
University of Turin
Start
Feb 2007
Primary completion
Dec 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of albumin (human) in Post-paracentesis Circulatory Dysfunction (PICD), sponsored by University of Turin. Status: unknown.

02

Drugs

albumin (human)
03

Conditions

Post-paracentesis Circulatory Dysfunction (PICD)

Beyond the preview

Go deeper on NCT00428506.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00428506.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call